Kane Biotech Inc. (CVE:KNE – Get Free Report)’s stock price rose 14.3% during trading on Thursday . The company traded as high as C$0.04 and last traded at C$0.04. Approximately 180,000 shares were traded during trading, an increase of 97% from the average daily volume of 91,567 shares. The stock had previously closed at C$0.04.
Kane Biotech Price Performance
The company has a market cap of C$6.65 million, a PE ratio of -0.44 and a beta of 0.23. The company has a debt-to-equity ratio of -331.42, a current ratio of 0.80 and a quick ratio of 0.39. The stock’s 50-day moving average is C$0.04 and its 200 day moving average is C$0.05.
Kane Biotech Company Profile
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
See Also
- Five stocks we like better than Kane Biotech
- Upcoming IPO Stock Lockup Period, Explained
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- 3 Stocks to Consider Buying in October
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
- 3 Fintech Stocks With Good 2021 Prospects
- MarketBeat Week in Review – 11/10 – 11/14
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
